In conclusion, this study shows that depletion of RIP140 improves the metabolic parameters of both glycolytic and oxidative muscles which participates in the overall phenotype of RIP140-null mice and suggest that RIP140 might be a potential therapeutic target in the treatment of insulin resistance in obese and type 2 diabetic patients. This evidence concerns the gene NRIP1 and type 2 diabetes mellitus.